VIRX Viracta Therapeutics, Inc.: Earnings per share for the trailing year

Public company logo of Viracta (VIRX)

Viracta Therapeutics (VIRX) develops targeted therapies for lymphomas, minimizing regulatory risks through a global network of trials. Historical EPS YoY TTM dynamics demonstrate the issuer's fundamental condition, with the metric reaching a value of 8.00. Long-term contracts and flexible supply routes ensure stability of supply. However, geopolitical tensions could slow the certification of new drugs due to disruptions in reagent supply chains.

viracta.com (VIRX): Net earnings per share for the last 12 months from 02/11/2024 to 02/20/2024

VIRX (Viracta Therapeutics, Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental company valuation:VIRX - Viracta Therapeutics Inc.
Original product of viracta.com

Under the Federal Reserve's tight monetary policy, capital protection against volatility becomes the investor's priority. This indicator measures the rate of change in net earnings per share over a rolling year, revealing the issuer's resilience to rising borrowing costs. By analyzing the percentage change in EPS YoY over 12 months, one can assess the efficiency of cost management. For Viracta Therapeutics (VIRX), which is currently in the clinical testing stage, this metric is critical due to the absence of stable cash flow. The trend of this indicator reflects the financial pressure on the company until the moment of drug commercialization.

Competitor analysis for Viracta Therapeutics

Earnings per share for the trailing year ONC (BeiGene)|Halozyme Inc. (HALO) - Earnings per share for the last twelve months|RevMed - Earnings per share for the trailing year|AAPG (Ascentage Pharma Group International) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CG Oncology, Inc. CGON|Net earnings per share for the last 12 months URGN (urogen.com)|Earnings per share for the last twelve months BCAX (Bicara Therapeutics)|Net earnings per share (EPS TTM) PSNL (personalis.com)|Earnings per share for the trailing year ERAS|DCTH - Earnings per share for the last twelve months|Y-mAbs Therapeutics (YMAB) - Net earnings per share for the last 12 months|AURA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CADL|Earnings per share for the last twelve months Accuray Inc.|SELLAS Life Sciences Group (SLS) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ACTU (Actuate Therapeutics, Inc)|Net earnings per share for the last four quarters Citius Oncology|TuHURA Biosciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Protara TARA|fatetherapeutics.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aadi Bioscience|TCRX: Net earnings per share (EPS TTM)|CSBR - Net earnings per share for the last four quarters|XBIT (XBiotech) - Net earnings per share (EPS TTM)|CVM: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OSTX|RADX (Radiopharm Theranostics Limited) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ARTV (Artiva Biotherapeutics, Inc.)|Earnings per share for the trailing year ANL|VERU: Net earnings per share for the last 12 months|TPST - Net earnings per share (EPS TTM)|XLO (xiliotx.com) - Net earnings per share for the last 12 months|Renovaro Biosciences - Earnings per share for the trailing year|Net earnings per share for the last 12 months MURA|Earnings per share for the last twelve months KAPA|Net earnings per share for the last 12 months OKUR (OnKure Therapeutics Inc)|Net earnings per share (EPS TTM) CytoMed (GDTC)|Earnings per share for the last twelve months curis.com CRIS|APLM (Apollomics, Inc.) - Earnings per one share for the last 12 months|Tharimmune Corporation - Net earnings per share (EPS TTM)|ADVB (advanbiomed.com) - Earnings per share for the last 12 months|Genprex, Inc (GNPX) - Earnings per share for the last twelve months|CLDI: Earnings per share for the last four quarters|SBFM (Sunshine Biopharma, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months XBIO (Xenetic Biosciences)|Net earnings per share (EPS TTM) SLRX|Purple Biotech - Earnings per share for the last 12 months|American Oncology Network - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGNE|CKPT - Earnings per share for the last twelve months|Elevation Oncology (ELEV) - Net earnings per share for the last 12 months|ICAD: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months MorphoSys Inc MOR|Earnings per share for the last twelve months NAYA Bio (NAYA)|AAPGV: Earnings per one share for the last 12 months